Cells as Cures

The recent demonstration of functional cure of Type 1 diabetes through stem-cell-derived islet transplantation marked an inflection point. Cell therapy is no longer experimental; it is becoming routine medicine. The CureForge Stem Cell & Regenerative Medicine Institute is the federation’s research engine for that transition. Eleven specialized AI systems collaborate across induced-pluripotent stem-cell derivation, lineage-specific differentiation, off-the-shelf allogeneic cell engineering with hypoimmunogenic-editing strategies, cell-therapy bioprocessing under goodmanufacturing-practice conditions, mesenchymal-stromal-cell therapeutics, exosomebased regenerative medicine, organoid-as-therapy approaches, in-vivo cell tracking and persistence, tumorigenicity and karyotype quality control, cell-therapy combination protocols with senolytic and immunomodulator therapies, and the functional-cure demonstration template now established by the leading clinical programs.

Value proposition:

• All major cell-therapy modalities under one research engine
• Bioprocessing automation from preclinical to good-manufacturing-practice scale
• Combination cell-plus-senolytic and cell-plus-immunomodulator design